Article
Preterm preeclampsia screening using biomarkers: combining phenotypic classifiers into robust prediction models.
American journal of obstetrics & gynecology MFM - 1 Oct 2023
Thomas Grégoire, Syngelaki Argyro, Hamed Karam, Perez-Montaño Anais, Panigassi Ana, Tuytten Robin, Nicolaides Kypros H
Abstract excerpt
BACKGROUND: Preeclampsia screening is a critical component of antenatal care worldwide. Currently, the most developed screening test for preeclampsia at 11 to 13 weeks' gestation integrates maternal demographic characteristics and medical history with 3 biomarkers-serum placental growth factor, mean arterial pressure, and uterine artery pulsatility index-to identify approximately 75% of women who develop preterm...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
